Comparing SECTOR 10 (SECI) & Varian Medical Systems (VAR)

Share on StockTwits

SECTOR 10 (OTCMKTS:SECI) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.

Institutional and Insider Ownership

92.0% of Varian Medical Systems shares are held by institutional investors. 0.7% of Varian Medical Systems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares SECTOR 10 and Varian Medical Systems’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
SECTOR 10 N/A N/A N/A N/A N/A
Varian Medical Systems $2.92 billion 4.25 $149.90 million $4.42 30.90

Varian Medical Systems has higher revenue and earnings than SECTOR 10.

Analyst Ratings

This is a summary of recent ratings and price targets for SECTOR 10 and Varian Medical Systems, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SECTOR 10 0 0 0 0 N/A
Varian Medical Systems 1 3 5 0 2.44

Varian Medical Systems has a consensus target price of $128.43, indicating a potential downside of 5.98%. Given Varian Medical Systems’ higher probable upside, analysts clearly believe Varian Medical Systems is more favorable than SECTOR 10.

Profitability

This table compares SECTOR 10 and Varian Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SECTOR 10 N/A N/A N/A
Varian Medical Systems 12.28% 26.18% 12.44%

Summary

Varian Medical Systems beats SECTOR 10 on 8 of the 8 factors compared between the two stocks.

SECTOR 10 Company Profile

Sector 10, Inc., a development stage company, markets the mobile response unit and stationary response unit products, and the PLX-3D technology. The company was founded in 2002 and is based in Salt Lake City, Utah.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. Varian Medical Systems, Inc. has a strategic partnership with Siemens AG to co-develop new imaging and treatment solutions. The company was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. Varian Medical Systems, Inc. was founded in 1948 and is headquartered in Palo Alto, California.

Receive News & Ratings for SECTOR 10 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SECTOR 10 and related companies with MarketBeat.com's FREE daily email newsletter.